.png)
HOUSTON, TX – April 1, 2022 InformAI,Inc., a digital healthcare company based in Houston, TX, is pleased to announce that Dr. Kyle Myers has joined the company as a senior advisor. In her key leadership role, Dr. Myers will provide advisory support for InformAI’s mission to advance healthcare through analytics and bringing AI-enabled imaging and clinical decision support products to the healthcare market.
“As a former FDA Director in the Division of Imaging, Diagnostics and Software Reliability, Dr. Kyle Myers brings tremendous technical and regulatory expertise to InformAI product development. We look forward to her expertise in obtaining regulatory approval to market our AI-enabled healthcare solutions in the US market,” said InformAI Founder and CEO, Jim Havelka.
Dr. Myers has also presented and published on the use of AI in medicine and on approaches for regulatory approval. She has worked on a variety of international collaborative projects in quantitative imaging, medical display technologies, computer-aided diagnostics, and multivariate statistical assessment methodologies.
“The regulatory process is a critical step in ensuring patient access to safe and effective medical devices to support their care. I look forward to working with the InformAI leadership team in deploying software-as-a-medical-device(SaMD) solutions to the market,” said Myers.
About InformAI
InformAI is an AI healthtech company that builds proprietary platforms for medical image disease detection and patient outcome/surgical risk prediction. The company's AI products speed up medical diagnosis at the point-of-care and improve physician productivity and risk management. InformAI products are focused on medical conditions and surgical procedures affecting head and neck and cardiac/thoracic organs. We develop our platforms with a team of experts from the Texas Medical Center, the world’s largest medical center complex, along with leading national physician groups and medical imaging/PACS companies. InformAI is also a selected company within the J&J JLABS-TMC, Texas Medical Center Innovation Center (TMCxi), and the NVIDIA Inception Program.
Press and Investor Relations Jackie Coleman +1 281-670-7085